CDH1 and cancer: As noted above, Gα13 signaling, through activation of AKT-GSK3β signaling, led to the loss of epithelial cell marker E-cad, gain of the mesenchymal cell marker vimentin and an increase in cancer cell invasion and metastasis [29].